Kathryn Swintek Net Worth

Kathryn Swintek biography

Kathryn B. Swintek is Independent Director of the Company. She has been a Managing Partner and member of the Investment Committee of Golden Seeds Fund 2, and Managing Director of Golden Seeds LLC, an angel investment forum backing women owned or managed early stage and growth companies. Prior to Golden Seeds, Ms. Swintek was a senior executive at BNP Paribas from November 1989 to April 2008, where she most recently served as Managing Director and Global Co-Head of its London-based Financial Sponsors Coverage Group. From 1974 to 1989, Ms. Swintek was a senior executive with Irving Trust Company (now known as BNY Mellon), where she was a Sr. Vice President and held positions in risk management and acquisition finance, and managed business relationships for the International Division in North Africa and the Near East, as well as in France, where she served as Representative while residing in Paris. Ms. Swintek is a former Chair of the Governing Board and the Executive Committee of The Committee of 200, a business women's leadership organization, which she joined in 2003. She serves on the Board of Directors of Bergen Medical Products, Inc., Turtle & Hughes, Inc., Open Road Integrated Media, Inc., and Oculogica Inc. She is a member of C200, the Women's Forum of New York, Women Corporate Directors, and Women Business Leaders of the U.S. Health Care Industry Foundation. The Company believes Ms. Swintek's qualifications to serve on the Board of Directors include her corporate leadership experience and her wide-ranging experience in international financial services.

How old is Kathryn Swintek?

Kathryn Swintek is 64, she's been the Independent Director of STRATA Skin Sciences Inc since 2013. There are 2 older and 7 younger executives at STRATA Skin Sciences Inc. The oldest executive at STRATA Skin Sciences Inc is Dr. Darrell S. Rigel, 70, who is the Chief Medical Advisor.

What's Kathryn Swintek's mailing address?

Kathryn's mailing address filed with the SEC is C/O STRATA SKIN SCIENCES, INC., 100 LAKESIDE DRIVE, STE. 100, HORSHAM, PA, 19044.

Insiders trading at STRATA Skin Sciences Inc

Over the last 9 years, insiders at STRATA Skin Sciences Inc have traded over $348,780 worth of STRATA Skin Sciences Inc stock and bought 2,664,087 units worth $2,970,754 . The most active insiders traders include Healthcare Master Fund Ltd ..., Lp22 Nw Fund, Lp22 Nw Fund ..., and Dolev Rafaeli. On average, STRATA Skin Sciences Inc executives and independent directors trade stock every 127 days with the average trade being worth of $392,199. The most recent stock trade was executed by Uri Geiger on 15 July 2024, trading 230,573 units of SSKN stock currently worth $723,999.

What does STRATA Skin Sciences Inc do?

formerly mela sciences, strata skin sciences is a new company built by unconventional thinkers. a medical technology company that brings hope and help to the dermatology patient in all of us. it’s not just a device or a technology, it’s optimism for psoriasis, determination for improving patients’ lives, and advocacy for getting it right.

STRATA Skin Sciences Inc executives and stock owners

STRATA Skin Sciences Inc executives and other stock owners filed with the SEC include:

• Michael R. Stewart,
  Independent Consultant
• Kathryn Swintek,
  Independent Director
• David Stone,
  Independent Director
• Samuel Navarro,
  Independent Director
• Jeffrey O'Donnell,
  Director
• James Coyne,
  Director
• Matthew Hill,
  Chief Financial Officer
• Dolev Rafaeli,
  Interim Chief Executive Officer
• Frank McCaney,
  President, Director
• LuAnn Via,
  Chairman of the Board
• Nikolai Kabelev,
  VP of R&D
• Shmuel Gov,
  Exec. VP & GM
• Dr. Darrell S. Rigel,
  Chief Medical Advisor
• Keith Simeone,
  VP of Sales
• Jay Sturm,
  Gen. Counsel & Corp. Sec.
• Christopher Lesovitz,
  Chief Financial Officer
• Robert J. Moccia,
  Pres, CEO & Director
• William D. Humphries,
  Exec. Chairman
• Healthcare Master Fund Ltd ...,
  
• Michael R Stewart,
  President & CEO
• Richard Rox Anderson,
  Director
• Christina L Allgeier,
  CFO
• David N Gill,
  
• Partners, L.P.Accelmed Part...,
  
• Douglas Strang,
  
• Samuel Rubinstein,
  
• Nachum Shamir,
  
• Christopher Lesovitz,
  Chief Financial Officer
• William D. Humphries,
  
• Uri Geiger,
  Director
• Wayne Cafran,
  
• Irit Yaniv,
  
• Patricia S Walker,
  
• Robert Joseph Moccia,
  Chief Executive Officer
• Lp22 Nw Fund, Lp22 Nw Fund ...,
  
• Shmuel Gov,
  COO